Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12614000617662
ACTRN12614000617662
Not Yet Recruiting
N/A

A randomized, double blind study testing the effect of indacaterol on exhaled and circulatory biomarkers of Chronic Obstructive Pulmonary Disease (COPD).

ung Institute of Western Australia0 sites200 target enrollmentJune 11, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ung Institute of Western Australia
Enrollment
200
Status
Not Yet Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ung Institute of Western Australia

Eligibility Criteria

Inclusion Criteria

  • •The people eligible for the study are patients with 1\)COPD. based on the criteria described below. 2\) Healthy controls with no COPD and within the same age range as subjects with COPD.
  • •1\.GOLD Criteria for severity of COPD
  • •a.Mild – FEV1/FVC\< 70%, FEV1\< 80%
  • •b.Moderate – FEV1/FVC\< 70%, FEV1 50\-80%
  • •2\.COPD chronic bronchitis or Emphysema
  • •3\.Age – 50\-70 years
  • •4\.males and females

Exclusion Criteria

  • •1\.Present smokers
  • •2\.Severe CCF
  • •3\.Liver, renal failure
  • •4\.Diabetes
  • •5\.On immunosuppressive drugs
  • •6\.Auto\-immune conditions such RA
  • •7\.Vascular disease – Scleroderma , SLE
  • •8\.Any history of asthma
  • •9\.Exacerbations in the last 6 weeks
  • •10\.Women of childbearing potential not using the contraception method(s) specified in this study (specify), as well as women who are breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
Randomised, double-blind study to demonstrate therapeutic equivalence of formoterol fumarate 12µg capsules delivered by Cyclohaler with Foradil in mild to moderate reversible obstructive airways disease.mild to moderate reversible obstructive airways disease
EUCTR2005-002538-37-GBPharmachemie B.V.30
Active, Not Recruiting
Phase 1
Effect of testosterone in male patients on regular hemodialysisHypogonadal males undergoing hemodialysis (HD).Therapeutic area: Diseases [C] - Hormonal diseases [C19]
EUCTR2011-005439-20-SEDept of Renal medicine40
Not Yet Recruiting
N/A
The effect of ultrasound-guided transversus abdominis plane block on post-operative pain in laparoscopic cholecystectomyDiseases of the digestive system
KCT0004835Soon Chun Hyang University Hospital Bucheon76
Active, Not Recruiting
Phase 1
Efficacy and safety of intravenous neridronic acid in CRPS-IComplex regional pain syndrome type I (CRPS-I)MedDRA version: 18.0Level: LLTClassification code 10064334Term: Complex regional pain syndrome Type ISystem Organ Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2014-001915-37-DEGrünenthal GmbH225
Active, Not Recruiting
Phase 1
Efficacy and safety of intravenous neridronic acid in CRPS-I
EUCTR2014-001915-37-GBGrünenthal GmbH225